606 related articles for article (PubMed ID: 10506699)
1. Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma.
Bonner JA; Garces YI; Sawyer TE; Gould PM; Foote RL; Deschamps C; Lange CM; Li H
Cancer; 1999 Oct; 86(7):1159-64. PubMed ID: 10506699
[TBL] [Abstract][Full Text] [Related]
2. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
4. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
5. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
[TBL] [Abstract][Full Text] [Related]
6. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
[TBL] [Abstract][Full Text] [Related]
8. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients.
Pfannschmidt J; Klode J; Muley T; Dienemann H; Hoffmann H
Ann Thorac Surg; 2006 Feb; 81(2):448-54. PubMed ID: 16427829
[TBL] [Abstract][Full Text] [Related]
9. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
[TBL] [Abstract][Full Text] [Related]
12. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
Varlotto JM; Flickinger JC; Recht A; Nikolov MC; DeCamp MM
Cancer; 2008 Apr; 112(7):1547-54. PubMed ID: 18260087
[TBL] [Abstract][Full Text] [Related]
13. Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer.
Whitson BA; Groth SS; Maddaus MA
Ann Thorac Surg; 2007 Sep; 84(3):1059-65. PubMed ID: 17720443
[TBL] [Abstract][Full Text] [Related]
14. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
15. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
16. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
17. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
[TBL] [Abstract][Full Text] [Related]
18. Is sampling really effective in staging non-small cell lung cancer? A prospective study.
Magnanelli G; Scanagatta P; Benato C; Terzi A; Lonardoni A; Falezza G; Furlan G; Calabrò F
Chir Ital; 2006; 58(1):19-22. PubMed ID: 16729605
[TBL] [Abstract][Full Text] [Related]
19. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
Zhang GQ; Han F; Gao SL; A DL; Pang ZL
Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
[TBL] [Abstract][Full Text] [Related]
20. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
